Continuum Clinical

Executive Summary

Continuum Clinical is a global clinical trial solutions provider specializing in patient engagement, recruitment, and retention. Founded in 1993, the company partners with biotech, pharmaceutical sponsors, and CROs to accelerate enrollment. Acquired by Spectrum Science in 2024, Continuum is now being integrated under the Spectrum brand, leveraging combined expertise to offer end-to-end patient-centric solutions. As a private entity, Continuum's financials are undisclosed, but its longevity and niche focus suggest a stable market position. The integration may unlock cross-selling opportunities and scale its digital health capabilities, positioning it for growth amid rising demand for decentralized trial technologies.

Upcoming Catalysts (preview)

• Q3 2026Completion of brand unification under Spectrum Science85% success
• Q4 2026Landing a major contract with a top-20 pharma sponsor60% success
• Q1 2027Launch of an AI-driven patient matching platform50% success